glp-1 binge eating New Insight: GLP‑1 medications—long used for diabetes—are now being explored for their role in disorder care, and the implications are complex. Why it matters: At much higher doses than for diabetes The therapeutic potential of GLP-1

Only one in 12 remain on a GLP-1 drug for obesity at three years owenhaskins Jun 26, 2025 2 min read Only 8% of individuals (or one in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to do so at three years, according to the latest real-world research from Prime Therapeutics (Prime)

Tran may recommend laboratory testing to measure your vitamin B12 levels, along with related markers like methylmalonic acid and homocysteine

2-O-(-D-Glucopyranosyl)ascorbic acid, a novel ascorbic acid analogue isolated from Lycium fruit

the decrease in HGF-dependent MDCK proliferation below control levels for some compounds is not surprising since the experiment was earned in 2% serum, which likely contains some level of HGF

It's a role I take seriously